SARS-CoV-2 productively infects human brain microvascular endothelial cells

Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroinflammation Jg. 19; H. 1; S. 149 - 17
Hauptverfasser: Yang, Rui-Cheng, Huang, Kun, Zhang, Hui-Peng, Li, Liang, Zhang, Yu-Fei, Tan, Chen, Chen, Huan-Chun, Jin, Mei-Lin, Wang, Xiang-Ru
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London BioMed Central 15.06.2022
BioMed Central Ltd
Springer Nature B.V
BMC
Schlagworte:
ISSN:1742-2094, 1742-2094
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood–brain barrier (BBB). Methods RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. Results A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Conclusions Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
AbstractList The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood-brain barrier (BBB). RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood-brain barrier (BBB).BACKGROUNDThe emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood-brain barrier (BBB).RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes.METHODSRNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes.A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins.RESULTSA total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins.Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.CONCLUSIONSOur findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood–brain barrier (BBB). Methods RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. Results A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Conclusions Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood-brain barrier (BBB). Methods RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. Results A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Conclusions Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection. Keywords: SARS-CoV-2, Human brain microvascular endothelial cells, Blood-brain barrier, Inflammatory response, Permeability
The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood-brain barrier (BBB). RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood–brain barrier (BBB). Methods RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. Results A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Conclusions Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
Abstract Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly contagious and has a high mortality rate in severe patients. However, there is very limited information on the effect of SARS-CoV-2 infection on the integrity of the blood–brain barrier (BBB). Methods RNA-sequencing profiling was performed to analyze the transcriptomic changes in human brain microvascular endothelial cells (hBMECs) after SARS-CoV-2 infection. Bioinformatic tools were used for differential analysis. Immunofluorescence, real-time quantitative PCR, and Western blotting analysis were used to explore biological phenotypes. Results A total of 927 differentially expressed genes were identified, 610 of which were significantly upregulated while the remaining 317 were downregulated. We verified the significant induction of cytokines, chemokines, and adhesion molecules in hBMECs by SARS-CoV-2, suggesting an activation of the vascular endothelium in brain. Moreover, we demonstrated that SARS-CoV-2 infection could increase the BBB permeability, by downregulating as well as remodeling the intercellular tight junction proteins. Conclusions Our findings demonstrated that SARS-CoV-2 infection can cause BBB dysfunction, providing novel insights into the understanding of SARS-CoV-2 neuropathogenesis. Moreover, this finding shall constitute a new approach for future prevention and treatment of SARS-CoV-2-induced CNS infection.
ArticleNumber 149
Audience Academic
Author Chen, Huan-Chun
Zhang, Yu-Fei
Li, Liang
Jin, Mei-Lin
Wang, Xiang-Ru
Zhang, Hui-Peng
Yang, Rui-Cheng
Huang, Kun
Tan, Chen
Author_xml – sequence: 1
  givenname: Rui-Cheng
  surname: Yang
  fullname: Yang, Rui-Cheng
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 2
  givenname: Kun
  surname: Huang
  fullname: Huang, Kun
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 3
  givenname: Hui-Peng
  surname: Zhang
  fullname: Zhang, Hui-Peng
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 4
  givenname: Liang
  surname: Li
  fullname: Li, Liang
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 5
  givenname: Yu-Fei
  surname: Zhang
  fullname: Zhang, Yu-Fei
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 6
  givenname: Chen
  surname: Tan
  fullname: Tan, Chen
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 7
  givenname: Huan-Chun
  surname: Chen
  fullname: Chen, Huan-Chun
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 8
  givenname: Mei-Lin
  surname: Jin
  fullname: Jin, Mei-Lin
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
– sequence: 9
  givenname: Xiang-Ru
  surname: Wang
  fullname: Wang, Xiang-Ru
  email: wangxr228@mail.hzau.edu.cn
  organization: State Key Laboratory of Agricultural Microbiology, The Cooperative Innovation Center for Sustainable Pig Production, College of Veterinary Medicine, Huazhong Agricultural University, Key Laboratory of Preventive Veterinary Medicine in Hubei Province
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35705998$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v3CAUtKpUzUf7B3qoLPXSi1PAYMyl0mqVNlEjVWraXhHGsMvKhi3Yq-Tf9znO10ZVhBAIZgbemznODnzwJsveY3SKcV19TpgITgtECEyGaXH9KjvCnJKCIEEPnuwPs-OUNgiVhFXkTXZYMo6YEPVR9v1q8fOqWIY_Bcm3MbSjHtzOdDe589boIeXrsVc-b6JyPu-djmGnkh47FXPj2zCsTedUl2vTdelt9tqqLpl3d-tJ9vvr2a_leXH549vFcnFZ6IqXQ0GNMII2dWVqwlpdc41oxXRjGWrKmmhGcFWWgmFNcW1bK6oWNYS0lipksNLlSXYx67ZBbeQ2ul7FGxmUk7cHIa6kioPTnZGCNxwThQ2jjDa2blqOLbXwaMWtKQlofZm1tmPTm1YbP0TV7Ynu33i3lquwkwKLGloLAp_uBGL4O5o0yN6lqR3KmzAmSSrOGfhQIoB-fAbdhDF6aNWEAjWCmXhErRQUADYEeFdPonLBEQfLGZv-ffofFIzWgEuQE-vgfI_w4WmhDxXeRwEA9QwAj1OKxkrtBjW4MNXtOomRnFIn59RJSJ28TZ28Bip5Rr1Xf5FUzqQEYL8y8bEbL7D-AWYA6H8
CitedBy_id crossref_primary_10_1038_s41598_024_82180_6
crossref_primary_10_1186_s12974_023_02856_0
crossref_primary_10_3390_cells11192959
crossref_primary_10_1007_s11357_024_01165_5
crossref_primary_10_1042_BST20220830
crossref_primary_10_3390_v16050785
crossref_primary_10_1007_s10753_024_02208_x
crossref_primary_10_1016_j_tim_2023_06_004
crossref_primary_10_3390_cells12050688
crossref_primary_10_1039_D4LC00848K
crossref_primary_10_1016_j_bbi_2023_01_010
crossref_primary_10_1177_10738584231194927
crossref_primary_10_3390_cimb46050277
crossref_primary_10_1007_s11357_024_01487_4
crossref_primary_10_1177_0271678X241277621
crossref_primary_10_3390_brainsci13050762
crossref_primary_10_1016_j_beem_2023_101842
crossref_primary_10_1016_j_cophys_2023_100670
crossref_primary_10_3389_fncel_2025_1553309
crossref_primary_10_3390_ijms241310432
crossref_primary_10_5501_wjv_v12_i2_68
crossref_primary_10_3389_fpain_2025_1527106
crossref_primary_10_1007_s00415_023_11684_4
crossref_primary_10_1186_s12987_024_00533_9
crossref_primary_10_3390_biology12081106
crossref_primary_10_1111_febs_16808
crossref_primary_10_1016_j_mehy_2023_111204
crossref_primary_10_3389_fmed_2024_1423241
crossref_primary_10_1097_ID9_0000000000000166
crossref_primary_10_1016_j_jneuroim_2024_578309
crossref_primary_10_3390_biom14121621
crossref_primary_10_1038_s41467_024_54917_4
crossref_primary_10_1186_s13567_024_01351_5
crossref_primary_10_3389_fneur_2025_1563040
crossref_primary_10_3390_ijms26125540
crossref_primary_10_1016_j_psychres_2022_114969
crossref_primary_10_1186_s12964_023_01383_y
crossref_primary_10_1016_j_bbi_2024_11_007
crossref_primary_10_1186_s12868_022_00728_6
crossref_primary_10_3389_fncel_2024_1481963
crossref_primary_10_3389_fnagi_2025_1587782
crossref_primary_10_3390_ijms26115102
crossref_primary_10_1038_s41401_022_00998_0
crossref_primary_10_3390_ijms24032377
crossref_primary_10_3389_fmicb_2024_1404312
crossref_primary_10_1089_vim_2023_0116
crossref_primary_10_1007_s00705_023_05711_y
crossref_primary_10_3390_neurolint15030052
crossref_primary_10_3389_fneur_2023_1172416
crossref_primary_10_3390_ijms24032852
crossref_primary_10_3389_fnhum_2024_1352118
crossref_primary_10_3390_biom14091081
crossref_primary_10_1186_s12985_024_02506_8
crossref_primary_10_1016_j_brainresbull_2024_110922
crossref_primary_10_1186_s12964_024_01488_y
crossref_primary_10_3390_ijms23179739
crossref_primary_10_7759_cureus_38194
crossref_primary_10_3390_v15061272
crossref_primary_10_1007_s12035_024_04044_4
crossref_primary_10_3390_v17030329
crossref_primary_10_1128_spectrum_04554_22
crossref_primary_10_1016_j_ijbiomac_2024_129731
Cites_doi 10.1007/s12035-020-02134-7
10.1016/S0140-6736(20)30183-5
10.1371/journal.ppat.1005926
10.1111/cns.13372
10.1016/j.immuni.2020.04.003
10.1016/j.autrev.2020.102572
10.1001/jamainternmed.2020.0994
10.1002/jmv.25783
10.1038/s41392-021-00719-9
10.3389/fphar.2020.00519
10.1242/jcs.00954
10.1172/JCI74159
10.1016/S0165-5728(97)00036-2
10.1038/nbt.3122
10.1002/jmv.25888
10.1006/mpat.2000.0406
10.1128/JVI.02154-14
10.1021/acsinfecdis.0c00564
10.1002/jmv.25915
10.1016/j.jns.2020.116832
10.1016/j.omtn.2018.10.013
10.1038/s41587-019-0050-1
10.1038/nrn1103
10.1001/jamaneurol.2020.2065
10.1056/NEJMc2010419
10.1007/s10571-018-0609-2
10.1038/s41593-021-00926-1
10.1016/j.devcel.2009.01.004
10.1186/s12974-018-1287-1
10.1016/j.bbi.2019.07.026
10.1038/s41577-020-0331-4
10.2174/092986707779941032
10.1093/infdis/161.4.685
10.1016/j.ijid.2020.03.062
10.3390/vaccines8030485
10.1007/978-81-322-1777-0_6
10.1016/j.chom.2020.05.020
10.1128/JVI.00602-20
10.1128/IAI.00336-10
10.1128/JVI.02012-06
10.1016/j.nbd.2009.07.030
10.1016/j.nbd.2020.105131
10.1111/all.14364
10.1016/j.neuroscience.2019.10.014
10.3389/fcvm.2021.687783
10.1126/science.abb8925
10.1038/s41577-020-0311-8
10.1371/journal.ppat.1000874
10.18632/oncotarget.11696
10.1016/j.omtn.2020.09.034
10.3389/fncel.2018.00386
10.1016/S2213-2600(20)30076-X
10.1016/S0140-6736(20)30566-3
10.1073/pnas.2005615117
10.1038/srep38903
10.1186/s12974-019-1497-1
10.1186/1471-2105-12-323
10.1016/j.cellsig.2019.109485
10.1038/nmeth.1923
10.1186/s13059-014-0550-8
10.1016/j.jaci.2020.04.027
10.1128/JVI.03149-13
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7T5
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12974-022-02514-x
DatabaseName Springer Nature Open Access Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Publicly Available Content Database

PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1742-2094
EndPage 17
ExternalDocumentID oai_doaj_org_article_97b712a1e5454bf8bd71f4fc8767fe32
PMC9198209
A707297552
35705998
10_1186_s12974_022_02514_x
Genre Journal Article
GeographicLocations China
Beijing China
United States--US
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GrantInformation_xml – fundername: National Key Research and Development Program of China
  grantid: 2021YDF1800405; 2021YDF1800800
– fundername: National Natural Science Foundation of China
  grantid: 32102749; 32122086
– fundername: China Agriculture Research System of MOF and MARA
  grantid: CARS-35
– fundername: Emergency Science and Technology Project of Hubei Province
  grantid: 2020FCA046
– fundername: National Key Research and Development Program of China
  grantid: 2021YDF1800800
– fundername: National Key Research and Development Program of China
  grantid: 2021YDF1800405
– fundername: National Natural Science Foundation of China
  grantid: 32122086
– fundername: National Natural Science Foundation of China
  grantid: 32102749
– fundername: ;
  grantid: 2020FCA046
– fundername: ;
  grantid: 32102749; 32122086
– fundername: ;
  grantid: CARS-35
– fundername: ;
  grantid: 2021YDF1800405; 2021YDF1800800
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
AFFHD
CITATION
-A0
3V.
ACRMQ
ADINQ
ALIPV
C24
NPM
7T5
7TK
7XB
8FK
AZQEC
COVID
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c673t-4e9e94b86e825dc87c0465cbf50b382c521633951c418fdf96d0b22df4a0e1ac3
IEDL.DBID 7X7
ISICitedReferencesCount 71
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000811739400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1742-2094
IngestDate Tue Oct 14 15:14:34 EDT 2025
Tue Nov 04 01:54:17 EST 2025
Sun Nov 09 14:28:09 EST 2025
Sat Oct 18 23:51:06 EDT 2025
Tue Nov 11 10:10:11 EST 2025
Tue Nov 04 17:59:00 EST 2025
Thu Jan 02 22:54:20 EST 2025
Tue Nov 18 22:34:08 EST 2025
Sat Nov 29 04:11:19 EST 2025
Sat Sep 06 07:29:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Inflammatory response
SARS-CoV-2
Permeability
Human brain microvascular endothelial cells
Blood–brain barrier
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c673t-4e9e94b86e825dc87c0465cbf50b382c521633951c418fdf96d0b22df4a0e1ac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2678202159?pq-origsite=%requestingapplication%
PMID 35705998
PQID 2678202159
PQPubID 55345
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_97b712a1e5454bf8bd71f4fc8767fe32
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9198209
proquest_miscellaneous_2677574230
proquest_journals_2678202159
gale_infotracmisc_A707297552
gale_infotracacademiconefile_A707297552
pubmed_primary_35705998
crossref_citationtrail_10_1186_s12974_022_02514_x
crossref_primary_10_1186_s12974_022_02514_x
springer_journals_10_1186_s12974_022_02514_x
PublicationCentury 2000
PublicationDate 2022-06-15
PublicationDateYYYYMMDD 2022-06-15
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-15
  day: 15
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Journal of neuroinflammation
PublicationTitleAbbrev J Neuroinflammation
PublicationTitleAlternate J Neuroinflammation
PublicationYear 2022
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References M Merad (2514_CR38) 2020; 20
TP Buzhdygan (2514_CR13) 2020; 146
H Kobayashi (2514_CR10) 2007; 14
I Alquisiras-Burgos (2514_CR35) 2020; 58
T Hirano (2514_CR37) 2020; 52
QQ Chai (2514_CR28) 2014; 88
R Yin (2514_CR32) 2020; 92
T Moriguchi (2514_CR34) 2020; 94
PB McCray (2514_CR53) 2007; 81
QQ Chai (2514_CR51) 2015; 89
R Yang (2514_CR20) 2020; 22
MI Love (2514_CR26) 2014; 15
KS Kim (2514_CR44) 2003; 4
RC Yang (2514_CR6) 2018; 13
JB Moore (2514_CR36) 2020; 368
X Xu (2514_CR45) 2020; 117
Z Xu (2514_CR31) 2020; 8
BJ Kim (2514_CR61) 2015; 125
R Yang (2514_CR19) 2016; 6
M Pertea (2514_CR23) 2015; 33
MF Stins (2514_CR17) 1997; 76
LK Zhu (2514_CR15) 2010; 78
ZY Wang (2514_CR52) 2020; 94
S Stonedahl (2514_CR54) 2020; 8
MMJ Al-Obaidi (2514_CR27) 2018; 38
X Cong (2514_CR58) 2020; 66
AM Baig (2514_CR4) 2020; 26
B Langmead (2514_CR24) 2012; 9
F Raucci (2514_CR41) 2020; 19
A Schubert-Unkmeir (2514_CR62) 2010; 6
B Dropulic (2514_CR57) 1990; 161
Y Zhang (2514_CR21) 2021; 95
AK Azkur (2514_CR43) 2020; 75
MZ Tay (2514_CR39) 2020; 20
A Paniz-Mondolfi (2514_CR33) 2020; 92
Q Zhou (2514_CR47) 2018; 15
CY Ma (2514_CR49) 2020; 11
S Raghavan (2514_CR14) 2021; 8
R Yang (2514_CR9) 2021; 7
C Wu (2514_CR40) 2020; 180
X Wang (2514_CR18) 2016; 12
F Takata (2514_CR48) 2019; 422
Z Liu (2514_CR50) 2019; 81
S Wan (2514_CR30) 2020; 92
M Desforges (2514_CR56) 2014; 807
MF Stins (2514_CR16) 2001; 30
K Bohmwald (2514_CR5) 2018; 12
E Dejana (2514_CR8) 2009; 16
SH Sun (2514_CR1) 2020; 28
AA Asadi-Pooya (2514_CR2) 2020; 413
AS Zubair (2514_CR55) 2020; 77
RC Yang (2514_CR60) 2019; 16
RF Thorne (2514_CR11) 2004; 117
CL Huang (2514_CR46) 2020; 395
L Zhang (2514_CR63) 2021; 6
NJ Abbott (2514_CR7) 2010; 37
R Yang (2514_CR59) 2016; 7
F Zhou (2514_CR3) 2020; 395
Y Yang (2514_CR42) 2020; 146
D Kim (2514_CR22) 2019; 37
J Wenzel (2514_CR12) 2021; 24
B Li (2514_CR25) 2011; 12
P Goyal (2514_CR29) 2020; 382
References_xml – volume: 58
  start-page: 520
  year: 2020
  ident: 2514_CR35
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-020-02134-7
– volume: 395
  start-page: 497
  year: 2020
  ident: 2514_CR46
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 12
  year: 2016
  ident: 2514_CR18
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1005926
– volume: 26
  start-page: 499
  year: 2020
  ident: 2514_CR4
  publication-title: CNS Neurosci Ther
  doi: 10.1111/cns.13372
– volume: 95
  start-page: 02477
  year: 2021
  ident: 2514_CR21
  publication-title: J Virol
– volume: 52
  start-page: 731
  year: 2020
  ident: 2514_CR37
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.003
– volume: 19
  year: 2020
  ident: 2514_CR41
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2020.102572
– volume: 180
  start-page: 934
  year: 2020
  ident: 2514_CR40
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2020.0994
– volume: 92
  start-page: 797
  year: 2020
  ident: 2514_CR30
  publication-title: J Med Virol
  doi: 10.1002/jmv.25783
– volume: 6
  start-page: 337
  year: 2021
  ident: 2514_CR63
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00719-9
– volume: 11
  start-page: 519
  year: 2020
  ident: 2514_CR49
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2020.00519
– volume: 117
  start-page: 373
  year: 2004
  ident: 2514_CR11
  publication-title: J Cell Sci
  doi: 10.1242/jcs.00954
– volume: 125
  start-page: 2473
  year: 2015
  ident: 2514_CR61
  publication-title: J Clin Invest
  doi: 10.1172/JCI74159
– volume: 76
  start-page: 81
  year: 1997
  ident: 2514_CR17
  publication-title: J Neuroimmunol
  doi: 10.1016/S0165-5728(97)00036-2
– volume: 33
  start-page: 290
  year: 2015
  ident: 2514_CR23
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3122
– volume: 92
  start-page: 1782
  year: 2020
  ident: 2514_CR32
  publication-title: J Med Virol
  doi: 10.1002/jmv.25888
– volume: 30
  start-page: 19
  year: 2001
  ident: 2514_CR16
  publication-title: Microb Pathog
  doi: 10.1006/mpat.2000.0406
– volume: 89
  start-page: 870
  year: 2015
  ident: 2514_CR51
  publication-title: J Virol
  doi: 10.1128/JVI.02154-14
– volume: 7
  start-page: 777
  year: 2021
  ident: 2514_CR9
  publication-title: ACS Infect Dis
  doi: 10.1021/acsinfecdis.0c00564
– volume: 92
  start-page: 699
  year: 2020
  ident: 2514_CR33
  publication-title: J Med Virol
  doi: 10.1002/jmv.25915
– volume: 413
  year: 2020
  ident: 2514_CR2
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2020.116832
– volume: 13
  start-page: 651
  year: 2018
  ident: 2514_CR6
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2018.10.013
– volume: 37
  start-page: 430
  year: 2019
  ident: 2514_CR22
  publication-title: Nat Biotechnol
  doi: 10.1038/s41587-019-0050-1
– volume: 4
  start-page: 376
  year: 2003
  ident: 2514_CR44
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1103
– volume: 77
  start-page: 1018
  year: 2020
  ident: 2514_CR55
  publication-title: Jama Neurol
  doi: 10.1001/jamaneurol.2020.2065
– volume: 382
  start-page: 2372
  year: 2020
  ident: 2514_CR29
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc2010419
– volume: 38
  start-page: 1349
  year: 2018
  ident: 2514_CR27
  publication-title: Cell Mol Neurobiol
  doi: 10.1007/s10571-018-0609-2
– volume: 24
  start-page: 1522
  year: 2021
  ident: 2514_CR12
  publication-title: Nat Neurosci
  doi: 10.1038/s41593-021-00926-1
– volume: 16
  start-page: 209
  year: 2009
  ident: 2514_CR8
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2009.01.004
– volume: 15
  start-page: 248
  year: 2018
  ident: 2514_CR47
  publication-title: J Neuroinflamm
  doi: 10.1186/s12974-018-1287-1
– volume: 81
  start-page: 630
  year: 2019
  ident: 2514_CR50
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2019.07.026
– volume: 20
  start-page: 355
  year: 2020
  ident: 2514_CR38
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-020-0331-4
– volume: 14
  start-page: 377
  year: 2007
  ident: 2514_CR10
  publication-title: Curr Med Chem
  doi: 10.2174/092986707779941032
– volume: 161
  start-page: 685
  year: 1990
  ident: 2514_CR57
  publication-title: J Infect Dis
  doi: 10.1093/infdis/161.4.685
– volume: 94
  start-page: 55
  year: 2020
  ident: 2514_CR34
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2020.03.062
– volume: 8
  start-page: 485
  year: 2020
  ident: 2514_CR54
  publication-title: Vaccines
  doi: 10.3390/vaccines8030485
– volume: 807
  start-page: 75
  year: 2014
  ident: 2514_CR56
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-81-322-1777-0_6
– volume: 28
  start-page: 124
  year: 2020
  ident: 2514_CR1
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.05.020
– volume: 94
  start-page: e00602-20
  year: 2020
  ident: 2514_CR52
  publication-title: J Virol
  doi: 10.1128/JVI.00602-20
– volume: 78
  start-page: 3554
  year: 2010
  ident: 2514_CR15
  publication-title: Infect Immun
  doi: 10.1128/IAI.00336-10
– volume: 81
  start-page: 813
  year: 2007
  ident: 2514_CR53
  publication-title: J Virol
  doi: 10.1128/JVI.02012-06
– volume: 37
  start-page: 13
  year: 2010
  ident: 2514_CR7
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2009.07.030
– volume: 146
  year: 2020
  ident: 2514_CR13
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2020.105131
– volume: 75
  start-page: 1564
  year: 2020
  ident: 2514_CR43
  publication-title: Allergy
  doi: 10.1111/all.14364
– volume: 422
  start-page: 12
  year: 2019
  ident: 2514_CR48
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2019.10.014
– volume: 8
  year: 2021
  ident: 2514_CR14
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2021.687783
– volume: 368
  start-page: 473
  year: 2020
  ident: 2514_CR36
  publication-title: Science
  doi: 10.1126/science.abb8925
– volume: 20
  start-page: 363
  year: 2020
  ident: 2514_CR39
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-020-0311-8
– volume: 6
  year: 2010
  ident: 2514_CR62
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000874
– volume: 7
  start-page: 63839
  year: 2016
  ident: 2514_CR59
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11696
– volume: 22
  start-page: 708
  year: 2020
  ident: 2514_CR20
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2020.09.034
– volume: 12
  start-page: 386
  year: 2018
  ident: 2514_CR5
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2018.00386
– volume: 8
  start-page: 420
  year: 2020
  ident: 2514_CR31
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 395
  start-page: 1054
  year: 2020
  ident: 2514_CR3
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30566-3
– volume: 117
  start-page: 10970
  year: 2020
  ident: 2514_CR45
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2005615117
– volume: 6
  start-page: 38903
  year: 2016
  ident: 2514_CR19
  publication-title: Sci Rep
  doi: 10.1038/srep38903
– volume: 16
  start-page: 101
  year: 2019
  ident: 2514_CR60
  publication-title: J Neuroinflamm
  doi: 10.1186/s12974-019-1497-1
– volume: 12
  start-page: 323
  year: 2011
  ident: 2514_CR25
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-12-323
– volume: 66
  year: 2020
  ident: 2514_CR58
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2019.109485
– volume: 9
  start-page: 357
  year: 2012
  ident: 2514_CR24
  publication-title: Nat Methods
  doi: 10.1038/nmeth.1923
– volume: 15
  start-page: 550
  year: 2014
  ident: 2514_CR26
  publication-title: Genome Biol
  doi: 10.1186/s13059-014-0550-8
– volume: 146
  start-page: 119
  year: 2020
  ident: 2514_CR42
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.04.027
– volume: 88
  start-page: 4698
  year: 2014
  ident: 2514_CR28
  publication-title: J Virol
  doi: 10.1128/JVI.03149-13
SSID ssj0032562
Score 2.5702176
Snippet Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2...
The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly...
Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2...
Abstract Background The emergence of the novel, pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health emergency....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 149
SubjectTerms Amino acids
Analysis
Annotations
Biomedical and Life Sciences
Biomedicine
Blood-brain barrier
Brain
Care and treatment
Cell adhesion & migration
Chemokines
Coronaviruses
COVID-19
Cytokines
Diagnosis
Endothelial cells
Endothelium
Experiments
Genes
Genomes
Health aspects
Human brain microvascular endothelial cells
Immune response
Immunofluorescence
Immunology
Infections
Inflammatory response
Laboratory animals
Measurement
Membrane permeability
Microvasculature
Neurobiology
Neurologic manifestations of general diseases
Neurology
Neuropathogenesis
Neurosciences
Permeability
Phenotypes
Proteins
Public health
Risk factors
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Transcriptomics
Viruses
Western blotting
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9UwFA8yRHwRv61OqSD4oGFJkybN43U4BHWI07G30KQJG1x7x3on87_3nKS9rhP1xdfmlCYn57M5-R1CXmgQA8fB-jklOyqdqkHnGKMt76JpRaNC6qJw-EHv7zdHR-bTpVZfWBOW4YEz43aMdppXLQ_g6qWLjes0jzJ60GIdg0jWl2kzJVPZBgtw5NV0RaZROwN4NS0pVq5jTC3pxcwNJbT-323yJad0tWDyyqlpckZ7t8mtMYosF3n2d8i10N8lNz6O5-T3yPuDxecDurs6pFV5mjFdwaotf5S59mooU2u-0mF_iPIb1uRNFall6Du8lLUEuSzxr_5wn3zde_tl9x0d2yZQr7RYUxlMMNIBmyH764BRHnLg2rtYMyeayoPDVkJAZOUlbyJsieqYq6ouypYF3nrxgGz1qz48ImXVQfjgHOR4kcsQXFMb5RiPCETXOuYLwicuWj9iimNri6VNuUWjbOa8Bc7bxHl7UZBXm3dOM6LGX6nf4OZsKBENOz0AGbGjjNh_yUhBXuLWWtRZmJ5vx6sHsEhEv7ILjfjpuq6BcntGCbrm58OTcNhR1wdbKcQchNDJFOT5ZhjfxPq1PqzOE42u8VCcFeRhlqXNkkStESSnKYieSdlszfOR_uQ4IYEbbuDT8N3Xkzz-mtafefr4f_D0CblZJX1SlNfbZGt9dh6ekuv--_pkOHuWtPEnFxk1ng
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SpringerLINK Contemporary 1997-Present
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA9yivji90f1lAiCDxps0jRJH9fDQ1APudXl3kKTJufB2j22e6L_vTNpu9rzA_S1mZBmMl9hJr8h5IkGMXAcrJ9TsmHSqRJ0Ls9ZzZtY1YVRIXVRWLzVBwfm6Kh6PzwK68Zq9zElmSx1UmujXnTgmbRkWH2OcbFkEDleBHdnsGHD4Xwx2t8CnLgYn8f8dt7EBSWk_l_t8U8O6Xyx5LmMaXJE-9f-bwvXydUh8KSzXlJukAuhvUkuvxtS67fIm_nscM72Vgsm6GkPAwuGcPmN9uVaHU3d_KjDlhL0M5bxjUWsNLQNvuNagihTTAR0t8nH_Vcf9l6zodMC80oXGyZDFSrp4GTgwth4oz1cm0vvYpm7wggPPl4VBQRjXnIT4RRVkzshmijrPPDaF3fITrtqwz1CRQMRh3NwLYxchuBMWSmX84jYdbXLfUb4yHzrBxhy7IaxtOk6YpTtuWSBSzZxyX7NyLPtnNMehOOv1C_xTLeUCKCdPqzWx3bQR1tpp7moeYAIUrpoXKN5lBG2rnQMhcjIU5QIi2oOv-fr4bUCbBIBs-xMI-S6Lkug3J1Qgnr66fAoU3YwD50VCmEKIdqqMvJ4O4wzseStDauzRKNLzKPnGbnbi-B2S0WpEVfHZERPhHOy5-lIe_IpgYdXvIKlYd3no4j--K0_8_T-v5E_IFdEknLFeLlLdjbrs_CQXPJfNifd-lFS1-9nMTpS
  priority: 102
  providerName: Springer Nature
Title SARS-CoV-2 productively infects human brain microvascular endothelial cells
URI https://link.springer.com/article/10.1186/s12974-022-02514-x
https://www.ncbi.nlm.nih.gov/pubmed/35705998
https://www.proquest.com/docview/2678202159
https://www.proquest.com/docview/2677574230
https://pubmed.ncbi.nlm.nih.gov/PMC9198209
https://doaj.org/article/97b712a1e5454bf8bd71f4fc8767fe32
Volume 19
WOSCitedRecordID wos000811739400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: Open Access: BioMedCentral Open Access Titles
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: RBZ
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: DOA
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: M~E
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1742-2094
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032562
  issn: 1742-2094
  databaseCode: RSV
  dateStart: 20041201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgQwgJ8TG-AmMKEhIPYC1OHNt5Qt20CQSrqhaq8mTFjgOTSlqaDo3_njsn6cgQe-GlUuqLksud786-8-8IeSlBDQwD62cELyg3IoU5F0U0Z0WZ5YkSzndRmH6Uw6GazbJRu-FWt2WVnU30hrpYWNwj348FIruBg8reLn9Q7BqF2dW2hcZ1so1ts1HP5Wyz4ErAncfdQRkl9mvwbZJTrF_HyJrT854z8pj9f1vmP1zT5bLJS7lT75KO7_4vM_fInTYYDQeN9twn11y1Q26etOn2HXK72dQLm7NKD8iHyWA8oYeLKY3DZQMVC8Zy_itsSrrq0Hf8Cw22nQi_Y6lfV-gauqrAs15zUPcQkwX1Q_L5-OjT4TvadmOgVshkTbnLXMYNSA8WlYVV0sLSOrWmTCOTqNhCHCCSBAI2y5kqQdKiiEwcFyXPI8dymzwiW9Wick9IGBcQlRgDS8eSceeMSjNhIlYivl1uIhsQ1olF2xaqHDtmzLVfsiihG1FqEKX2otTnAXm9uWfZAHVcSX2A0t5QIsi2_2Ox-qrbOaszaSSLc-YgyuSmVKaQrOQlsC5k6ZI4IK9QVzSaAng9m7cnGoBJBNXSA4mw7DJNgXK3RwlT2PaHOzXRrQmp9YWOBOTFZhjvxLK4yi3OPI1MMdceBeRxo5wblpJUIvaOCojsqW2P5_5IdfrNA4xnLINHw3PfdAp-8Vr__qZPr-biGbkV-6knKEt3ydZ6deaekxv25_q0Xu35iet_1R7ZPjgajsZ7fn8ErkbvT0Zf4Go8mf4GQwlOnQ
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VggAJ8SivQAEjgTiAVe_a3rUPCIVC1SpphWipclu86zVUCk6IU2j_FL-RmbWd4iJ664Frdhzv2PP0znwD8EyiGGiG1k-LKPcjLWLUuSDwM5YXaRYmwropCvtDubOTjEbphyX41fbCUFllaxOdoc4nhr6Rr3FByG7ooNI30-8-TY2i09V2hEYtFgN7_BNTtur11jt8v88533i_t77pN1MFfCNkOPcjm9o00rgLTI5yk0iDKWJsdBEHOky4QX8mwhADDxOxpMAdizzQnOdFlAWWZSbE_70AF9GOS0r25GiR4IUYPvC2MScRaxX6Uhn5VC9PkXzkH3Wcn5sR8Lcn-MMVni7TPHVW61zgxo3_7eHdhOtNsO31a-24BUu2XIHL2005wQpcqz9aenUv1m0Y7PY_7vrrk32fe9MaChedwfjYq0vWKs9NNPQ0jdXwvlEpY1vI69kyp162MaqzR4ch1R34dC6s3YXlclLa--DxHKMurTE1LlhkrU7iVOiAFYTfl-nA9IC1YqBMA8VOE0HGyqVkiVC16CgUHeVERx314OXimmkNRHIm9VuSrgUlgYi7HyazL6qxSSqVWjKeMYtRdKSLROeSFVGBrAtZ2JD34AXJpiJTh9szWdOxgUwSaJjqS4Kdl3GMlKsdSjRRprvciqVqTGSlTmSyB08Xy3Qllf2VdnLoaGRMtQRBD-7VyrBgKYwlYQslPZAdNenw3F0pD746APWUpXhrvO-rVqFOtvXvZ_rgbC6ewJXNve2hGm7tDB7CVe7UXvgsXoXl-ezQPoJL5sf8oJo9dkbDg8_nrWi_ASy5pQw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfQhiZeGJ8jMCBISDyAtdhx7OSxDCrQRjVRqPZmxY4Nk0paNR2C_547JynL-JAQr_FZju37su7ud4Q8VcAGhoH2M1JUVBiZgcwlCS1Z5YsyzaULXRRmx2oyyU9Pi5MLVfwh270PSbY1DYjSVK8PlpVvRTyXBw1YKSUoZqKjjywoeJHbAhPp8b0-nfW6OAWDzvtSmd_OG5ijgNr_q26-YJwuJ05eip4GozTe_f_t3CDXO4c0HrUcdJNccfUtsvOuC7nfJkfT0fspPVzMKI-XLTwsKMj597hN42ri0OUvNthqIv6C6X19cmvs6grru-bA4jEGCJo75OP49YfDN7TrwECtVOmaCle4Qhi4MXhIVjZXFp7TmTU-S0yacwu2X6YpOGlWsNzD7coqMZxXXpSJY6VN75KtelG7eyTmFXgixsBz0TPhnMmzQpqEecS0K01iI8L6i9C2gyfHLhlzHZ4pudTtKWk4JR1OSX-LyPPNnGULzvFX6pd4vxtKBNYOHxarT7qTU10ooxgvmQPPUhifm0oxLzxsXSrvUh6RZ8gdGsUffs-WXRUDbBKBtPRIIRS7yjKg3B9Qgtja4XDPX7pTG43mEuELwQsrIvJkM4wzMRWudovzQKMyjK8nEdlr2XGzpTRTiLeTR0QNGHWw5-FIffY5gIoXrIClYd0XPbv-_K0_n-n9fyN_THZOXo318dvJ0QNyjQeGl5Rl-2RrvTp3D8lV-3V91qweBSn-ARqsRho
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+productively+infects+human+brain+microvascular+endothelial+cells&rft.jtitle=Journal+of+neuroinflammation&rft.au=Yang%2C+Rui-Cheng&rft.au=Huang%2C+Kun&rft.au=Zhang%2C+Hui-Peng&rft.au=Li%2C+Liang&rft.date=2022-06-15&rft.pub=BioMed+Central+Ltd&rft.issn=1742-2094&rft.eissn=1742-2094&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12974-022-02514-x&rft.externalDocID=A707297552
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon